10x Genomics Reports Third Quarter 2021 Financial Results

PLEASANTON, Calif.: PLEASANTON, Calif., Nov. 3, 2021 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the third quarter ended September 30, 2021. Recent Highlights Revenue was $125.3 million for the third quarter, representing a 74% increase over the corresponding period of 2020 and an 8% increase...

Click to view original post